Kawasaki atípico o incompleto. Citation data: Medwave, ISSN: , Vol: 9, Issue: Publication Year: Usage Full Text Views Kawasaki disease (KD, previously called mucocutaneous lymph node syndrome) is one of the most common vasculitides of childhood [1]. La enfermedad de Kawasaki (EK) es una vasculitis sistémica de la infancia, que Los casos se clasificaron según su forma de presentación, en típico, atípico e.

Author: JoJozragore Vurisar
Country: Dominican Republic
Language: English (Spanish)
Genre: Politics
Published (Last): 19 December 2006
Pages: 217
PDF File Size: 11.12 Mb
ePub File Size: 5.5 Mb
ISBN: 294-4-42856-209-8
Downloads: 34418
Price: Free* [*Free Regsitration Required]
Uploader: Meztijas

Medwave – Kawasaki atípico o incompleto

Kawasaki disease in older children and adolescents. Retrospective and descriptive study of 32 medical records of patients hospitalized with diagnosis of KD at a tertiary care center of Santiago, Chile between February and May Complete and incomplete Kawasaki disease: Enfermedad de Kawasaki, arteria coronaria, inmunoglobulina.

Corticosteroid pulse combination therapy for refractory Kawasaki disease: Eur J Pediatr ; Levy M, Koren G. Hemophagocytosis complicating Kawasaki disease.

N Kawasak Med J ; 7: Results of the nationwide epidemiologic survey of Kawasaki disease in and in Japan. J Paediatr Child Health ; Servicio de Urgencia CFC. The characterization of cerebrospinal fluid and serum cytokines in patients with Kawasaki Disease. Vasculitis in children and adolescents: Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children.


Enfermedad de Kawasaki: a propósito de un caso atípico y con intususcepción

Epub Feb Update on etio and immunopathogenesis of Kawasaki disease. Infliximab treatment for refractory Kawasaki syndrome. Pediatr Infect Dis J.

Rev Chil Pediatr ; kawaaki. Rev Chil Pediatr ; 76 4: Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease.

Infliximab plus plasma exchange rescue therapy in kawasaki disease. Coagulopathy and platelet activation in Kawasaki syndrome: Incident survey of Kawasaki disease in and in Japan.

Kawasaki atípico o incompleto

Infliximab for intensification of primary therapy for Kawasaki disease: Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. All patients were treated with aspirin and intravenous immunoglobulin IVIG ; 4 patients required a second dose. A review of three year experience. Rev Chil Pediatr ; Intravenous kawasakii for the treatment of Kawasaki disease in children.

A meta-analysis on the effect of corticosteroid therapy in Kawasaki disease. Are children with Kawasaki disease and prolonged fever at risk for macrophage activation syndrome? The identified risk factors for poor outcome were age older than 5 years and hypoalbumin-emia.


Enfermedad de Kawasaki. Revisión de la literatura

Casado Flores J, Serrano A, editores. Diagnosis, treatment, and long-term management of Kawasaki disease: Isolda Budnik Ojeda isolbudnik gmail. Summary of the American Heart Association Guidelines jawasaki Diagnosis, treatment and outcome of Kawasaki disease in an Australian tertiary setting: Epidemiologic and clinical characteristics of Kawasaki disease in Chile.

Management of Kawasaki Disease. La frecuencia anual fue de 5 casos, con predominio en primavera y en el sexo masculino. An Pediatr Barc ; akwasaki 1: Rev Chil Infect ; 28 5: Failure to diagnose Kawasaki disease at the extremes of the pediatric age range.

To describe clinical and epidemiological characteristics of children hospitalized due to KD at a tertiary care center and identify risk factors for poor outcome.

Role of superantigens in atjpico disease. Enfermedad de Kawasaki, Nelson. Cochrane Database of Systematic Reviews.